» Articles » PMID: 34846639

Radiotherapy Alone for Pediatric Patients with Craniopharyngioma

Overview
Journal J Neurooncol
Publisher Springer
Date 2021 Nov 30
PMID 34846639
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Radiotherapy alone, without tumor-directed surgery, may be appropriate for selected patients with craniopharyngioma reducing the risks associated with neurosurgery. Understanding outcomes for patients with craniopharyngioma treated with radiotherapy alone will further refine patient selection and treatment options.

Methods: Since 2002, 13 children, adolescents and young adults, with craniopharyngioma were treated with radiotherapy alone and followed for disease control and functional outcomes at a single institution. The median age at treatment was 13 years (range, 3-21 years). All patients received 54 Gy/54 Gy(RBE) in 30 fractions. Five patients were treated with intensity-modulated photon therapy, four with passively scattered proton therapy, and four with intensity-modulated proton therapy.

Results: With a median follow-up of 5 years (range 3 months-14 years), all patients were alive. One experienced tumor progression 8.5 years after treatment. No significant changes in vision, hearing or neurologic function attributed to radiotherapy. Hormone deficiencies and body mass index were within the expected range at baseline and 5 years after treatment. There was no evidence of cognitive decline based on assessment of IQ, memory and attention. Unexpected complications included single cases of out-of-field malignancy, white matter changes, large vessel narrowing, and pontine capillary telangiectasia. Six patients had sphenoid bone abnormalities on follow-up imaging attributed to radiotherapy.

Conclusion: Radiotherapy alone is an important treatment option to consider when radical resection is contraindicated, or surgical intervention is not required to alleviate symptoms. Disease control and functional outcomes are excellent after radiation therapy alone in appropriately selected patients.

Citing Articles

Outcomes of endoscopic endonasal surgery for pediatric craniopharyngioma with a focus on morphological preservation of the pituitary stalk and endocrine functions.

Kino H, Akutsu H, Tanaka S, Iwabuchi A, Hara T, Morinaga Y Pituitary. 2025; 28(2):34.

PMID: 40042666 DOI: 10.1007/s11102-025-01506-3.


Current state and promise of user-centered design to harness explainable AI in clinical decision-support systems for patients with CNS tumors.

Prince E, Mirsky D, Hankinson T, Gorg C Front Radiol. 2025; 4:1433457.

PMID: 39872709 PMC: 11769936. DOI: 10.3389/fradi.2024.1433457.


Radiation therapy for childhood-onset craniopharyngioma: systematic review and meta-analysis.

Miao Y, Wu D, Li Y, Ji Y, Sang Y J Neurooncol. 2025; 172(1):89-98.

PMID: 39751704 DOI: 10.1007/s11060-024-04914-w.


Impact of stereotactic radiotherapy for craniopharyngioma: a large, academic hospital cohort.

Mauro G, Da Roz L, Gico V, Weltman E, De Souza E, Villar R Childs Nerv Syst. 2024; 41(1):11.

PMID: 39607561 DOI: 10.1007/s00381-024-06686-0.


The Iterative Design Process of an Explainable AI Application for Non-Invasive Diagnosis of CNS Tumors: A User-Centered Approach.

Prince E, Hankinson T, Gorg C IEEE Workshop Vis Anal Healthc. 2024; 2023:7-13.

PMID: 38989292 PMC: 11235084. DOI: 10.1109/vahc60858.2023.00008.


References
1.
Madsen P, Buch V, Douglas J, Parasher A, Lerner D, Alexander E . Endoscopic endonasal resection versus open surgery for pediatric craniopharyngioma: comparison of outcomes and complications. J Neurosurg Pediatr. 2019; 24(3):236-245. DOI: 10.3171/2019.4.PEDS18612. View

2.
Varlotto J, DiMaio C, Grassberger C, Tangel M, Mackley H, Pavelic M . Multi-modality management of craniopharyngioma: a review of various treatments and their outcomes. Neurooncol Pract. 2019; 3(3):173-187. PMC: 6668277. DOI: 10.1093/nop/npv029. View

3.
Fouda M, Scott R, Marcus K, Ullrich N, Manley P, Kieran M . Sixty years single institutional experience with pediatric craniopharyngioma: between the past and the future. Childs Nerv Syst. 2019; 36(2):291-296. DOI: 10.1007/s00381-019-04294-x. View

4.
Minniti G, Esposito V, Amichetti M, Enrici R . The role of fractionated radiotherapy and radiosurgery in the management of patients with craniopharyngioma. Neurosurg Rev. 2009; 32(2):125-32. DOI: 10.1007/s10143-009-0186-4. View

5.
Zhang C, Verma V, Lyden E, Horowitz D, Zacharia B, Lin C . The Role of Definitive Radiotherapy in Craniopharyngioma: A SEER Analysis. Am J Clin Oncol. 2017; 41(8):807-812. DOI: 10.1097/COC.0000000000000378. View